Minimal residual disease detection in autologous stem cell grafts from patients with high risk neuroblastoma

Author(s):
Wezel, E.M. van; Stutterheim, J.; Vree, F.; Zappeij-Kannegieter, L.; Decarolis, B.; Hero, B.; Berthold, F.; Schumacher-Kuckelkorn, R.; Simon, T.; Fiocco, M.; Voermans, C.; Noesel, M.M. van; Caron, H.N.; Schoot, C.E. van der; Tytgat, G.A.M.; GPOH MRD Study Grp
Published
2015
Publication type
Article / Letter to editor
autologous stem cell transplantationhigh riskMRDneuroblastomaPBSC
Date issued
2015-08-31
Language
English
Is part of
Pediatric Blood & Cancer (2015), Vol. 62, no. 8, p. 1368-1373
hdl
1887/105676
doi
10.1002/pbc.25507